New research conducted at the Lady Davis Institute (LDI) at the Jewish General Hospital reveals that a novel drug reverses memory deficits and stops Alzheimer disease pathology (AD) in an animal model. Importantly, this drug has already proven to be non-toxic for humans in a clinical setting and could, therefore, be brought quickly to trials...
Tag: <span>Alzheimer’s disease (AD)</span>
Post
Alzheimer’s drug may stop disease if used before symptoms develop
August 1, 2018 by Fariss Samarrai, University of Virginia About 50 percent of people who reach the age of 85 will develop Alzheimer’s disease. Most will die within about five years of exhibiting the hallmark symptoms of the disease – severe memory loss and a precipitous decline in cognitive function. The reddish-blue mouse neurons in this...
Post
Can nanotechnology help treat Alzheimer’s?
June 19, 2018 by Ileana Varela, Florida International University Alzheimer’s disease (AD) is the most common form of dementia. It takes a devastating toll on patients and family members, who are usually the caregivers. Current drugs only treat symptoms of AD, not its causes. June is Alzheimer’s and Brain Awareness Month. FIU researchers are studying a new approach...
Post
Brain astrocytes linked to Alzheimer’s disease
Astrocytes, the supporting cells of the brain, could play a significant role in the pathogenesis of Alzheimer’s disease (AD), according to a new study from the University of Eastern Finland. This is the first time researchers have discovered a direct association between astrocytes and AD. Published in Stem Cell Reports, the study investigated the brain cell...
Post
Investigating patterns of degeneration in Alzheimer’s disease
Alzheimer’s disease (AD) is known to cause memory loss and cognitive decline, but other functions of the brain can remain intact. The reasons cells in some brain regions degenerate while others are protected is largely unknown. In a paper to be published in Stem Cell Reports, researchers from Brigham and Women’s Hospital have found that factors...
Post
How studying Alzheimer’s in China could unlock its secrets
Alzheimer’s disease (AD) is the most common form of dementia, affecting some 46 million people globally, and a leading cause of mortality in the elderly. There are two major hurdles to overcome in developing effective treatments. First, our understanding of the disease pathology is still incomplete. Second, by the time an individual is diagnosed, the...
- 1
- 2